Skip Nav Destination
Issues
1 July 2023
-
Cover Image
Cover Image
The cover image is adapted from Figure 2 in the article, “Cancer InFocus: Tools for Cancer Center Catchment Area Geographic Data Collection and Visualization,” by Burus and colleagues. The National Cancer Institute (NCI) added Community Outreach and Engagement (COE) requirements for NCI-designated cancer centers in 2017, including the charge of characterizing the cancer burden in the geographic area served by their center (i.e., catchment area). Doing so helps cancer centers better identify needs and areas of inequality in their populations to guide research and outreach. To accomplish this, current and comprehensive data must be gathered from multiple sources and analyzed by the COE—a task that is tedious and inefficient. The authors present an efficient solution, known as Cancer InFocus, to collect and visualize quantitative data that they have generalized for use by other cancer centers on their catchment areas. Cancer InFocus delivers a choice of two routes for creating interactive online mapping applications that visualize cancer incidence and mortality rates, along with relevant social determinant and risk factor variables, at various geographic levels for a defined cancer center catchment area. Figure 2 shows examples of output from the final interface for both ArcGIS Online and Shiny versions of Cancer InFocus. Cancer InFocus provides tools for cancer centers to accomplish the critical task of maintaining current and comprehensive catchment area data. The open-source format will help future enhancements through user collaboration. For more information, see the article beginning on page 889. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1055-9965
EISSN 1538-7755
Issue Sections
Highlights
Commentaries
Review
Resource Report
Research Articles
Hepatocellular Carcinoma Surveillance among Individuals with Cirrhosis: Trends by Payer, Etiology, and Calendar Year, from a Statewide, Multi-Payer Dataset, 2010–2018
Christine D. Hsu; Louise M. Henderson; Bradford E. Jackson; Christopher D. Baggett; Michele Jonsson Funk; Andrew F. Olshan; Parul Gupta; A. Sidney Barritt, 4th; Hanna K. Sanoff; Stephanie B. Wheeler; Andrew M. Moon; Jennifer L. Lund
Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer
Alyssa N. Troeschel; Terryl J. Hartman; Lauren E. McCullough; Isaac J. Ergas; Lindsay J. Collin; Marilyn L. Kwan; Christine B. Ambrosone; W. Dana Flanders; Patrick T. Bradshaw; Elizabeth M. Cespedes Feliciano; Janise M. Roh; Ying Wang; Emily Valice; Lawrence H. Kushi
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.